Anika Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	276	133	237	332	433	517
Market Cap Growth	135.89%	-43.75%	-28.57%	-23.26%	-16.34%	-20.22%
Enterprise Value	262.59	100.19	205.67	289.37	375.39	442.28
Last Close Price	20.61	9.61	16.46	22.66	29.60	35.83
PE Ratio	-	-	-	-	197.33	127.96
Forward PE	23.03	53.39	39.19	72.08	72.08	112.55
PEG Ratio	2.32	11.40	1.96	3.60	3.60	161.40
PS Ratio	2.28	1.18	1.98	2.75	3.80	3.50
PB Ratio	2.02	0.93	1.54	1.57	1.52	1.80
P/TBV Ratio	2.27	1.03	1.68	1.64	2.15	2.66
P/FCF Ratio	489.12	30.60	-	-	-	159.01
P/OCF Ratio	45.99	11.93	43.92	-	98.19	61.62
EV/Sales Ratio	2.17	0.89	1.72	2.40	3.30	2.99
EV/EBITDA Ratio	511.18	-	68.10	19.21	20.67	18.90
EV/EBIT Ratio	-	-	-	342.86	102.29	169.13
EV/FCF Ratio	465.70	22.97	-	-	-	135.92
Debt / Equity Ratio	0.17	0.17	0.16	0.12	0.10	0.07
Debt / EBITDA Ratio	45.54	-	7.95	1.72	1.59	0.82
Debt / FCF Ratio	41.49	5.55	-	-	-	5.91
Net Debt / Equity Ratio	-0.11	-0.23	-0.20	-0.20	-0.20	-0.26
Net Debt / EBITDA Ratio	-29.49	6.25	-10.47	-2.84	-3.17	-3.21
Net Debt / FCF Ratio	-26.86	-7.63	13.56	5.94	18.69	-23.09
Asset Turnover	0.65	0.57	0.51	0.39	0.33	0.41
Inventory Turnover	1.93	2.30	1.82	1.19	1.07	1.58
Quick Ratio	3.05	3.71	3.40	3.06	4.33	4.17
Current Ratio	4.48	4.72	4.88	5.26	6.07	5.66
Return on Equity (ROE)	-2.22%	-6.71%	-4.82%	-1.38%	0.77%	1.48%
Return on Assets (ROA)	-2.94%	-6.03%	-6.88%	-0.30%	0.54%	1.25%
Return on Invested Capital (ROIC)	-4.59%	-10.19%	-11.17%	-0.46%	0.85%	2.19%
Return on Capital Employed (ROCE)	-3.11%	-6.35%	-2.43%	0.30%	1.15%	0.81%
Earnings Yield	-	-	-	-	0.51%	0.78%
FCF Yield	0.20%	3.27%	-	-	-	0.63%
Buyback Yield / Dilution	4.23%	2.59%	-0.44%	0.89%	-1.05%	-2.90%
Total Shareholder Return	4.23%	2.59%	-0.44%	0.89%	-1.05%	-2.90%

SEC Filings: 10-K · 10-Q